Englewood Lab Inc

950140 · KQ · Consumer Defensive / Household & Personal Products

6,120.00KRW+10.00 (+0.16%)

Price History

Full chart

Market Stats

Previous Close6,110.00

Open6,220.00

Day Range6,120.00 – 6,280.00

52-Week Range7,000.00 – 16,910.00

Volume3.44K

Market Cap162.52B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield2.46%

Beta0.28

50-Day Avg8,468.20

200-Day Avg10,417.35

About

Englewood Lab, Inc. engages in the research, development, manufacture, and sale of cosmetic products in the United States, Korea, Canada, China, Japan, Europe, and internationally. It offers masks, cleansers, and anti-aging skincare products, as well as face, eye, and body moisturizer; primers and foundations, BB and CC Cream, concealer, blush and illuminizers, bronzer highlighter, and lip care; and over the counter products, such as SPF/ACNE, personal hygiene, and skin protectant. The company was founded in 2004 and is headquartered in Totowa, New Jersey. Englewood Lab, Inc. operates as a subsidiary of Cosmecca Korea Co., Ltd.

Company Details

SectorConsumer Defensive
IndustryHousehold & Personal Products
CEOMr. Im-Rae Cho
Employees0
Headquarters20 Campus Road, Totowa, NJ, United States, 07512, Korea
Websitehttps://www.englewoodlab.com

Leadership

Mr. Im-Rae ChoCEO & Director · b. 1953
Ms. Eun-Hee ParkCEO & Director · b. 1957
Mr. Hyun Suk ChoPresident · b. 1981
Mr. Gi-Hyun KimCFO & Director · b. 1964

Financials

Income Statement

Currency: KRW	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	0	143.14B	68.23M	77.05M	107.94M	114.37M	116.24M	140.52M	117.27M	158.41M	133.59M	216.79B
Growth (%)	-	-	-99.95%	+12.93%	+40.08%	+5.96%	+1.63%	+20.89%	-16.55%	+35.08%	-15.66%	+162174.77%
Cost of Revenue	0	109.20B	50.94M	66.02M	90.26M	92.19M	94.92M	110.38M	97.26M	121.80M	105.34M	156.77B
Gross Profit	0	33.94B	17.29M	11.04M	17.68M	22.18M	21.32M	30.15M	20.01M	36.61M	28.26M	60.02B
Gross Margin	-	23.71%	25.34%	14.32%	16.38%	19.40%	18.34%	21.45%	17.06%	23.11%	21.15%	27.69%
Operating Expense	-6.18B	19.11B	14.89M	22.49M	21.08M	16.40M	14.63M	15.34M	12.36M	14.50M	14.48M	22.66B
Operating Income	6.18B	14.83B	2.40M	-11.45M	-3.39M	5.79M	6.69M	14.81M	7.65M	22.10M	13.78M	37.37B
Operating Margin	-	10.36%	3.52%	-14.87%	-3.14%	5.06%	5.75%	10.54%	6.52%	13.95%	10.31%	17.24%
EBITDA	-	-	-	-	-	-	-	-	13.68B	33.81B	31.77B	42.14B
EBITDA Margin	-	-	-	-	-	-	-	-	11664.28%	21342.62%	23778.95%	19.44%
Net Income	0	13.27B	-244.49K	-12.27M	-5.36M	1.95M	2.61M	13.10M	5.62M	15.89M	14.39M	24.81B
Net Income Margin	-	9.27%	-0.36%	-15.93%	-4.97%	1.70%	2.25%	9.33%	4.80%	10.03%	10.77%	11.45%
R&D	-	-	-	-	-	-	2.26B	2.44B	2.43B	2.22B	2.81B	3.13B
R&D as % of Total Revenue	-	-	-	-	-	-	1947.65%	1734.51%	2074.56%	1399.99%	2101.61%	1.45%
Interest Expense	0	0	0	0	0	0	976.24M	741.10M	977.36M	698.93M	906.85M	1.16B
Interest Expense % of Total Revenue	-	0.00%	0.00%	0.00%	0.00%	0.00%	839.85%	527.39%	833.42%	441.23%	678.81%	0.53%

Balance Sheet

Currency: KRW	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	46.21B	69.89M	86.29M	93.71M	99.62M	99.92M	108.12M	106.82M	134.67M	135.87M	227.04B
Total Liabilities	19.56B	7.99M	29.98M	42.99M	46.83M	44.16M	39.84M	33.42M	45.54M	37.98M	62.45B
Total Equity	26.65B	61.90M	56.31M	50.72M	52.79M	55.76M	68.28M	73.41M	89.12M	97.89M	164.59B
Cash	870.59M	620	6.55M	984.64K	4.71M	9.45M	5.33K	7.31K	9.26K	8.71K	36.07B
Total Debt	-	-	13.39M	18.61M	14.85M	17.16M	-	-	-	-	-
Net Debt	-	-	-	-	19.81B	8.86B	16.05B	11.50B	-	-	-

Cash Flow

Currency: KRW	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-470.03M	-1.13B	-2.90M	-8.98B	-9.37B	12.12B	7.30B	-6.86B	9.56B	16.01M	9.47M	22.39B
Investing Cash Flow	-18.55B	-44.51B	-12.97M	-12.26B	-5.39B	-4.37B	5.26B	-2.20B	-4.18B	-6.01M	-5.74M	-
Financing Cash Flow	19.76B	47.43B	32.63M	9.49B	8.57B	-3.47B	-7.46B	6.87B	-3.67B	-9.82M	7.56M	-
Capital Expenditure	1.97B	4.72B	5.10M	10.25B	13.21B	4.90B	3.98B	2.37B	4.10B	2.02M	3.70M	6.74B
Free Cash Flow	-	-	-	-	-	5.77B	3.31B	-9.34B	5.34B	18.04B	8.48B	15.65B
Dividends Paid	3.70B	8.89B	-	-	-	-	-	-	-	-	1.49M	2.00B
FCF to OCF	-	-	-	-	-	47.66%	45.40%	136.11%	55.80%	112681.47%	89495.48%	69.90%
Dividend Paid to FCF	-	-	-	-	-	-	-	-	-	-	0.02%	12.75%

Key Statistics & Ratios

Market Cap162.52B

Enterprise Value124.11B

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.74

Price / Book0.90

Revenue (TTM)218.19B

Gross Profit (TTM)60.52B

EBITDA42.62B

Profit Margin14.86%

Operating Margin16.83%

Return on Equity20.18%

Return on Assets10.27%

Shares Outstanding19.87M

Shares Float3.48M

Beta0.28

Dividend Yield2.46%

Dividend Rate201.21

Payout Ratio12.31%